5AM Ventures — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Kinaset Therapeuticskinasettherapeutics.com in 𝕏Jul 2020✓ verified

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)Frazer Morgan(Chief Development Officer / Co-Founder)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investorsAtlas Venture RA Capital EQT Life Sciences Sixty Degree Capital Vivo Capital Gimv +1 more

SurrozenJun 2020

BiotechSouth San Francisco, US

Anna Berkenblit(Director)Harold Varmus(Director)

BoardDavid Goeddel(Director)Craig Parker(Executive Officer, Director)Tim Kutzkey(Director)

Co-investorsThe Column Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.